Pfizer says it will decide in 2018 whether to split its generics and branded businesses but M&A experts are already predicting how the giant will get rid of its established drugs programme.
Hefei will manufacture the API for Oramed's oral insulin tablet as part of a potential $50m licensing deal in China, Hong Kong and Macau.
ManKind Pharma plans to set up manufacturing facilities in Northeast India to bring production in-house and cut its tax bill.
In-Pharmatechnologist.com's round-ups of the industry's latest clinical and executive hires.
The number of pharmaceutical cargo thefts has fallen in recent years, but manufacturers still need to be vigilant according to an expert who says the holidays are a risky period.
Teva has teamed with Heptares to develop and commercialise easily-deliverable small-molecule calcitonin gene-related peptide (GPCR) antagonists to treat migraine.